Identifying the potential role of curcumin analogues as anti-breast cancer agents; an in silico approach

Identifying the potential role of curcumin analogues as anti-breast cancer agents; an in silico approach

Abstract Background Breast cancer ranks top among newly reported cancer cases and most of the women suffers from breast cancer. Development of target therapy using phytochemicals with minimal side effects is trending in health care research. Phytochemicals targets complex multiple signalling events...

Full description

Bibliographic Details
Main Authors:	N. G. Praseetha, U. K. Divya, S. Nair
Format:	Article
Language:	English
Published:	SpringerOpen 2022-06-01
Series:	Egyptian Journal of Medical Human Genetics
Subjects:	Curcumin analogues Molecular docking Ferulic acid Breast cancer
Online Access:	https://doi.org/10.1186/s43042-022-00312-x

Similar Items

Curcumin analogues exert potent inhibition on human and rat gonadal 3β-hydroxysteroid dehydrogenases as potential therapeutic agents: structure-activity relationship and in silico docking
by: Xinyi Qiao, et al.
Published: (2023-12-01)

In Silico Analysis for Exploring the Potential Inhibitors Against Breast Cancer (MCF7) Using Curcumin Analogue Compounds
by: Neni Frimayanti, et al.
Published: (2024-06-01)

A Review of Recent Curcumin Analogues and Their Antioxidant, Anti-Inflammatory, and Anticancer Activities
by: Kirandeep Kaur, et al.
Published: (2024-09-01)

Curcumin Inhibits the Primary Nucleation of Amyloid-Beta Peptide: A Molecular Dynamics Study
by: Irini Doytchinova, et al.
Published: (2020-09-01)

Chemical Modification of Curcumin into Its Semi-Synthetic Analogs Bearing Pyrimidinone Moiety as Anticancer Agents
by: Obaid Afzal, et al.
Published: (2022-10-01)

Hybridization of Curcumin Analogues with Cinnamic Acid Derivatives as Multi-Target Agents Against Alzheimer’s Disease Targets
by: Eirini Chainoglou, et al.
Published: (2020-10-01)

Computational Exploration of Multitarget Effects of Curcumin in Breast Cancer Treatment
by: Siddhartha Bethi, et al.

Design, Synthesis, and Molecular Docking Studies of Curcumin Hybrid Conjugates as Potential Therapeutics for Breast Cancer
by: Siva S. Panda, et al.
Published: (2022-04-01)

Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative review
by: Maryam Golmohammadi, et al.
Published: (2024-12-01)

Curcumin: Synthesis optimization and in silico interaction with cyclin dependent kinase
by: Ahmed Mahmood, et al.
Published: (2017-09-01)

Evaluating a series of new curcumin derivatives as potential anti-breast cancer agents: A collective analysis of in-vitro and in-silico characterization
by: R. Yuvashri, et al.
Published: (2024-12-01)

Effects of Curcumin and Ferulic Acid on the Folding of Amyloid-β Peptide
by: Evdokiya Salamanova, et al.
Published: (2021-05-01)

Synthesis, DFT Analyses, Antiproliferative Activity, and Molecular Docking Studies of Curcumin Analogues
by: Mohamed Jawed Ahsan, et al.
Published: (2022-10-01)

Correction of mitochondrial dysfunction with trimethoxy-substituted monocarbonyl curcumin analogues in experimental Alzheimer’s disease
by: D. I. Pozdnyakov, et al.
Published: (2024-01-01)

Development of Computational In Silico Model for Nano Lipid Carrier Formulation of Curcumin
by: Omar Waleed Abduljaleel Albasri, et al.
Published: (2023-02-01)

Molecular Engineering of Curcumin, an Active Constituent of <i>Curcuma longa</i> L. (Turmeric) of the Family <i>Zingiberaceae</i> with Improved Antiproliferative Activity
by: Amena Ali, et al.
Published: (2021-07-01)

Curcumin Suppresses Lead-Induced Inflammation and Memory Loss in Mouse Model and In Silico Molecular Docking
by: Suksan Changlek, et al.
Published: (2022-03-01)

Design, synthesis and biological evaluation of a series of new resveratrol analogues as potential anti-cancer agents
by: Lifang Yang, et al.
Published: (2019-09-01)

In Silico Pharmacokinetics Study of 2,5-Dibenzylidenecyclopentanone Analogs as Mono-Ketone Versions of Curcumin
by: Marbun Prajona, et al.
Published: (2023-01-01)

Antiemetic activity of trans-ferulic acid possibly through muscarinic receptors interaction pathway: In vivo and in silico study
by: Md. Shimul Bhuia, et al.
Published: (2023-12-01)

Molecular docking of ferulic acid, bakuchiol and niazirin on peroxisome proliferator-activated receptor gamma (PPAR-γ) as anti-diabetic agents
by: Anjar Hermadi Saputro, et al.
Published: (2024-08-01)

Curcumin as a potential inhibitor of TGFβ3 computational insights for breast cancer therapy
by: Ali G. Alkhathami, et al.
Published: (2025-01-01)

Discovery of Novel Mono-Carbonyl Curcumin Derivatives as Potential Anti-Hepatoma Agents
by: Weiya Cao, et al.
Published: (2023-09-01)

Antitumoral Activities of Curcumin and Recent Advances to ImProve Its Oral Bioavailability
by: Marta Claudia Nocito, et al.
Published: (2021-10-01)

Folate-Targeted Curcumin-Loaded Niosomes for Site-Specific Delivery in Breast Cancer Treatment: In Silico and In Vitro Study
by: Banafsheh Honarvari, et al.
Published: (2022-07-01)

The Role of BNCT in Breast Cancer Treatment
by: B. Poedjomartono, et al.
Published: (2019-12-01)

Development of Provesicular Nanodelivery System of Curcumin as a Safe and Effective Antiviral Agent: Statistical Optimization, In Vitro Characterization, and Antiviral Effectiveness
by: Farid A. Badria, et al.
Published: (2020-12-01)

Physicochemical properties and drug likeness of hydroxycinnamic acids and their molecular docking with caffeine and amoxicillin: Potential anticancer drugs
by: Umer Sherefedin, et al.
Published: (2025-01-01)

Ultrasonic-Assisted Synthesis of Heterocyclic Curcumin Analogs as Antidiabetic, Antibacterial, and Antioxidant Agents Combined with in vitro and in silico Studies
by: Zelelew D, et al.
Published: (2023-07-01)

Study of Molecular Docking and Prediction of Toxicity of Morin Analogues as Anti-Cancer Agents and Aromatase Inhibitors
by: Tooba Abdizadeh
Published: (2023-10-01)

Chemical evaluation and application of cinnamaldehyde-derived curcumins as potential fingerprint development agents
by: Tais Poletti, et al.
Published: (2022-12-01)

Novel-Substituted Heterocyclic GABA Analogues. Enzymatic Activity against the GABA-AT Enzyme from Pseudomonas fluorescens and In Silico Molecular Modeling
by: Erika Tovar-Gudiño, et al.
Published: (2018-05-01)

Design of Novel Letrozole Analogues Targeting Aromatase for Breast Cancer: Molecular Docking, Molecular Dynamics, and Theoretical Studies on Gold Nanoparticles
by: Alaa Edris, et al.
Published: (2023-04-01)

<i>In Silico</i> Pesticide Discovery for New Anti-Tobacco Mosaic Virus Agents: Reactivity, Molecular Docking, and Molecular Dynamics Simulations
by: Hala A. Abdulhassan, et al.
Published: (2022-03-01)

Inhibitions of monoamine oxidases by ferulic acid hydrazide derivatives: synthesis, biochemistry, and computational evaluation
by: Arshida Thottile Peedikayil, et al.
Published: (2023-10-01)

Hansch analysis by QSAR model of curcumin and eight of its transformed derivatives with antimicrobial activity against Staphylococcus aureus
by: Dini Kesuma, et al.
Published: (2024-09-01)

Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach
by: Shopnil Akash, et al.
Published: (2023-03-01)

Corrigendum: Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: a computational drug design approach
by: Shopnil Akash, et al.
Published: (2023-06-01)

Molecular Pathways Modulated by Curcumin Analogue, Diarylpentanoids in Cancer
by: Felicia Paulraj, et al.
Published: (2019-07-01)

Synthetic Curcumin Analogues Present Antiflavivirus Activity In Vitro with Potential Multiflavivirus Activity from a Thiazolylhydrazone Moiety
by: Mateus Sá Magalhães Serafim, et al.
Published: (2023-03-01)